Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
02/12/2004 | WO2003050502A3 Prospective identification and characterization of breast cancer stem cells |
02/12/2004 | WO2003050301A3 Susceptibility locus for schizophrenia |
02/12/2004 | WO2003039485A3 Stable liquid pharmaceutical formulation of igg antibodies |
02/12/2004 | WO2003039346A3 Diagnostics and therapeutics for ocular abnormalities |
02/12/2004 | WO2003033670A3 Method for preparation of single chain antibodies |
02/12/2004 | WO2003033653B1 Affinity enhancement agents |
02/12/2004 | WO2003016470A3 Enhancing the efficacy of immunotherapies by supplementing with complement |
02/12/2004 | WO2003010282A3 Interleukin-1 beta antibodies |
02/12/2004 | WO2002100330A3 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
02/12/2004 | WO2002095051A3 Mage-a3 peptides presented by hla class ii molecules |
02/12/2004 | WO2002090542A8 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
02/12/2004 | WO2002077232A3 Compositions and methods relating to breast specific genes and proteins |
02/12/2004 | WO2002068461A3 Heterocarpine, a human ghrh-binding protein |
02/12/2004 | WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same |
02/12/2004 | WO2002066063A8 Remedies for metabolic bone diseases |
02/12/2004 | WO2002059609A3 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
02/12/2004 | WO2002059299A3 Expression cloning method |
02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
02/12/2004 | WO2002057411A3 Hydrolase enzymes and their use in kinetic resolution |
02/12/2004 | WO2002053700A3 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
02/12/2004 | WO2002046411A3 Intestinal proteins |
02/12/2004 | WO2002035981A3 Methods and compositions for the treatment of human immunodeficiency virus infection |
02/12/2004 | US20040031073 Method for modifying plant morphology, biochemistry and physiology |
02/12/2004 | US20040030115 Nucleic acids containing the coding regions of the genes encoding such proteins, vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins; useful for diagnosing and treating disorders related to them |
02/12/2004 | US20040030112 Use of these kinases as targets for isolating specific inhibitors or antagonists of the kinase activity, the inhibitors are anticipated to have use as contraceptive agents |
02/12/2004 | US20040030106 Novel compounds and process |
02/12/2004 | US20040030103 Anti-idiotype inducing antibodies, comprising at least one epitope from angiodenin, for the inhibition of angiogenesis |
02/12/2004 | US20040029775 Methods and compounds for influencing beta3-integrin-dependent intracellular processes |
02/12/2004 | US20040029280 Viral vectors with modified tropism |
02/12/2004 | US20040029268 Endothelialization of vascular surfaces |
02/12/2004 | US20040029246 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
02/12/2004 | US20040029234 Enhanced 2-keto-l-gulonic acid production |
02/12/2004 | US20040029232 Novel G-protein coupled receptors |
02/12/2004 | US20040029228 Cytokine receptor |
02/12/2004 | US20040029221 Identification and isolation of novel DNA and the recombinant production of novel polypeptides; for detecting the presence of tumors in mammals |
02/12/2004 | US20040029217 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/12/2004 | US20040029197 Novel human cancer/testis antigen and gene thereof |
02/12/2004 | US20040029169 Nogo Receptor (NgR)-p75; myelins; for drug screening; cell-free |
02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
02/12/2004 | US20040029147 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
02/12/2004 | US20040029118 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments |
02/12/2004 | US20040029115 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously |
02/12/2004 | US20040029113 Cleaving single-stranded nucleic acid sequences by contacting with a oligonucleotide; restriction endonuclease recognition site; fab fragments |
02/12/2004 | US20040028700 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
02/12/2004 | US20040028687 Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues |
02/12/2004 | US20040028685 EphA2 monoclonal antibodies and methods of use thereof |
02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
02/12/2004 | US20040028682 Inhibiting transforming growth factor beta to prevent accumulation of extracellular matrix |
02/12/2004 | US20040028681 Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist |
02/12/2004 | US20040028680 Complexing fibroblast growth factor ; controlling elimination from cell |
02/12/2004 | US20040028677 Chimeric allograft tolerance induction, monitoring and maintenance |
02/12/2004 | US20040028669 Human gene critical to fertility |
02/12/2004 | US20040028667 Mixture containing probiotic bacteria; stability |
02/12/2004 | US20040028648 Administering integrins; prevent tissue swelling |
02/12/2004 | US20040027537 Continuous two-dimensional corneal topography target |
02/12/2004 | DE10234116A1 Preparation of recombinant single-chain Fv fragments in plants, useful for control of plant and human viral infections, comprises using an expression vector |
02/12/2004 | CA2505849A1 Novel tricistronic vectors and uses therefor |
02/12/2004 | CA2494310A1 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
02/12/2004 | CA2494121A1 Modulation of mesenchymal cells via iga-receptors |
02/12/2004 | CA2494115A1 Mutants of ige proteins and uses thereof |
02/12/2004 | CA2492457A1 Antibodies against c3a receptor |
02/12/2004 | CA2487528A1 Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation |
02/11/2004 | EP1388544A1 Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof |
02/11/2004 | EP1388543A2 Antibodies against phosphorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
02/11/2004 | EP1387889A2 Kinases and phosphatases |
02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
02/11/2004 | EP1387886A2 Proteases |
02/11/2004 | EP1387698A2 Method of preventing cell death using antibodies to neural thread proteins |
02/11/2004 | EP1387697A2 Methods of treating antibody-mediated pathologies using agents which inhibit cd21 |
02/11/2004 | EP1387696A2 Anti-ige antibody to treat ocular allergies |
02/11/2004 | EP1387674A2 Hedgehog antagonists, methods and uses related thereto |
02/11/2004 | EP0970377B1 Diagnosis of epithelial cell abnormalities |
02/11/2004 | EP0922225B1 Assay for quantifying arthritic conditions |
02/11/2004 | EP0888452B1 Human cyr61, an extracellular matrix signalling molecule |
02/11/2004 | EP0858467B1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
02/11/2004 | EP0835124B1 Serum preparations for inhibiting retroviruses and tumor growth |
02/11/2004 | EP0804482B1 Cytokines that bind the cell surface receptor hek |
02/11/2004 | EP0506868B2 Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine |
02/11/2004 | CN1474872A Method for modifying plant morphology, biochemistry and physiology |
02/11/2004 | CN1473925A Heterotrophic medium composition for transgenenic chlorella |
02/11/2004 | CN1473854A Recombined IL4 antibody for treating IL4 insertion diseases |
02/11/2004 | CN1473853A Anti-bacteria endotoxin chicken ritellus antibody and its preparation and its use |
02/11/2004 | CN1473850A New human protein with mouse NIH/3T3 cell transformation improving function and its code sequence |
02/11/2004 | CN1473849A Novel human protein with cancer inhibiting function and its code sequence |
02/11/2004 | CN1473846A Method for producing rabbit alexin by high density heterotrophically cultivating transgenosis chlorella |
02/11/2004 | CN1137779C Method for preparing 3,4-dichlorophenylnitrile by using ammonia oxidation process and its special purpose catalyst |
02/11/2004 | CN1137727C Process for preparation of immune globulin for introvenous injection by dual inactivation of virus without protectives |
02/11/2004 | CN1137726C Method of prolonged suppression of humoral immunity |
02/10/2004 | US6689877 Administering a therapeutic amount of nebr1 antiretroviral transcriptional factor to hiv infected cells in patient |
02/10/2004 | US6689869 Labeled humanized anti-CD18 antibodies and fragments and kits comprising same |
02/10/2004 | US6689868 Isolated antibody which selectively binds to isolated cd2bp1 protein having specified amino acid sequence |
02/10/2004 | US6689866 Isolated polypeptide comprising specified amino acid sequence; membrane-bound or secreted polypeptide having semaphorin-like activity |
02/10/2004 | US6689864 Isolated polypeptide comprising cyclin dependent kinase 4 inhibitor or biologically active fragment thereof, encoded by dna molecule consisting of specified sequence |
02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
02/10/2004 | US6689751 Peptide comprising amino acid sequence 15 or 83 with alanine or alpha-aminoisobutyrate substitution |
02/10/2004 | US6689611 Modified Streptomyces host cells for increased avermectin production and methods of making the same |
02/10/2004 | US6689598 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
02/10/2004 | US6689597 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
02/10/2004 | US6689585 GABA-B2 receptor |